Skip to main content

Feasibility of using Bortezomib-based immunosuppressive approach to deplete anti-AAV antibodies in mice

Research Grant
Duke Scholars

Administered By

Pediatrics, Medical Genetics

Awarded By

Asklepios BioPharmaceutical, Inc.

Start Date

December 1, 2018

End Date

November 30, 2020
 

Administered By

Pediatrics, Medical Genetics

Awarded By

Asklepios BioPharmaceutical, Inc.

Start Date

December 1, 2018

End Date

November 30, 2020